ADA Scientific Sessions 2026 Abstract
Beyond Insulin Alone: One-Year CGM Outcomes of Adjunctive Incretin-Based and SGLT2 Inhibitors Therapy in Type 1 Diabetes Using Open-Source Automated Insulin Delivery Systems
Cohort study of 357 peopleSGLT2 inhibitors